JMS Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2017
November 10, 2016 at 09:30 am EST
Share
JMS Co., Ltd. announced consolidated earnings results for the six months ended September 30, 2016. For the period, the company reported net sales of JPY 27,526 million against JPY 28,147 million a year ago. Operating income JPY 592 million against JPY 523 million a year ago. Ordinary income was JPY 699 million against JPY 430 million a year ago. Profit attributable to the owners of parent was JPY 409 million or JPY 8.41 per share against JPY 288 million or JPY 5.91 per share a year ago. Net cash provided by operating activities was JPY 2,399 million against JPY 1,522 million a year ago. Purchase of property, plant and equipment was JPY 3,689 million against JPY 3,247 million a year ago. Purchase of intangible assets was JPY 82 million against JPY 36 million a year ago.
For the fiscal year ending March 31, 2017 on consolidated basis, the company expects to report consolidated net sales of JPY 56,000 million, operating income of JPY 1,100 million, ordinary income of JPY 1,200 million, and profit attributable to the owners of parent of JPY 900 million or JPY 18.47 per share.
JMS CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The Company operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The Company is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Companyâs main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The Company is also involved in the provision of maintenance service and other related services.
JMS Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2017